BMC Medical Valuation

Is 301367 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301367 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301367 (CN¥70.8) is trading below our estimate of fair value (CN¥137.16)

Significantly Below Fair Value: 301367 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301367?

Key metric: As 301367 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 301367. This is calculated by dividing 301367's market cap by their current earnings.
What is 301367's PE Ratio?
PE Ratio	41.4x
Earnings	CN¥151.98m
Market Cap	CN¥6.29b

301367 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.8x
Enterprise Value/EBITDA	32.9x
PEG Ratio	1.3x

Price to Earnings Ratio vs Peers

How does 301367's PE Ratio compare to its peers?

The above table shows the PE ratio for 301367 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	82.1x
603301 Zhende Medical	30.3x	36.9%	CN¥6.2b
688085 Shanghai Sanyou Medical	143.8x	45.2%	CN¥5.4b
300206 Edan Instruments	43.6x	n/a	CN¥6.8b
300326 Shanghai Kinetic Medical	110.9x	40.5%	CN¥4.4b
301367 BMC Medical	41.4x	32.9%	CN¥6.3b

Price-To-Earnings vs Peers: 301367 is good value based on its Price-To-Earnings Ratio (41.4x) compared to the peer average (82.1x).

Price to Earnings Ratio vs Industry

How does 301367's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 301367 is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the CN Medical Equipment industry average (37.3x).

Price to Earnings Ratio vs Fair Ratio

What is 301367's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301367 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	41.4x
Fair PE Ratio	33.1x

Price-To-Earnings vs Fair Ratio: 301367 is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the estimated Fair Price-To-Earnings Ratio (33.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 301367 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥70.80	CN¥79.63 +12.5%	7.2%	CN¥87.55	CN¥74.34	n/a	3
Nov ’25	CN¥72.33	CN¥82.18 +13.6%	10.5%	CN¥94.20	CN¥74.34	n/a	3
Oct ’25	CN¥79.80	CN¥82.18 +3.0%	10.5%	CN¥94.20	CN¥74.34	n/a	3
Sep ’25	CN¥65.63	CN¥86.39 +31.6%	9.0%	CN¥94.20	CN¥78.57	n/a	2
Aug ’25	CN¥71.71	CN¥86.39 +20.5%	9.0%	CN¥94.20	CN¥78.57	n/a	2
Jul ’25	CN¥62.32	CN¥86.39 +38.6%	9.0%	CN¥94.20	CN¥78.57	n/a	2
Jun ’25	CN¥58.20	CN¥86.39 +48.4%	9.0%	CN¥94.20	CN¥78.57	n/a	2
May ’25	CN¥64.48	CN¥102.81 +59.5%	8.4%	CN¥111.43	CN¥94.20	n/a	2

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.2b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.51

-1.3%

-30.9%

Innovita Biological Technology

CN¥6.0b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥44.00

1.1%

52.7%

iRay Technology

CN¥16.7b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥112.93

-5.6%

-30.5%